SELF-EMULSIFYING PHARMACEUTICAL COMPOSITIONS OF HYDROPHILIC DRUGS AND PREPARATION THEREOF

• US 20100273730A1
• Filed: 04/26/2010
• Published: 10/28/2010
• Est. Priority Date: 04/27/2009
• Status: Abandoned Application

• Current Assignee: InnoPharmax, Inc.
• Original Assignee: InnoPharmax, Inc.
• Inventors: Hsu, Chang-Shan, Hao, Wei-Hua, Wang, Jong-Jing, Lin, Tsung-Hsin
• Application Number:
  US12/767,293
• Publication Number:
  US 20100273730A1
• Time in Patent Office: Days
• US Class Current: 514/49
• CPC Class Codes: A61K 31/4184 condensed with carbocyclic rings, e.g. benzimidazoles
• CPC Class Codes: A61K 31/7068 having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
• CPC Class Codes: A61K 9/1075 Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers A61K9/0026 takes precedence
• CPC Class Codes: A61K 9/4858 Organic compounds
• CPC Class Codes: A61K 9/4866 Organic macromolecular compounds
• CPC Class Codes: A61P 35/00 Antineoplastic agents
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention provides an oral self micro-emulsifying pharmaceutical composition of a hydrophilic drug or a pharmaceutically acceptable salt thereof which, in addition to the hydrophilic drug, one or more solvents for solving the hydrophilic drug to form a drug-solvent solution and a surfactant system, further comprises one or more hydrophilic carrier which are compatible with said drug-solvent solution and the surfactant system. The oral self micro-emulsifying pharmaceutical composition of the invention exhibits comparative bioavailability to that of the hydrophilic drug through injection and is stable during storage. A method for preparing the oral self micro-emulsifying pharmaceutical composition is also provided.

Claims

1. An oral self micro-emulsifying pharmaceutical composition, which comprises:

(a) a therapeutically effective amount of a hydrophilic drug or its pharmaceutically acceptable salt;

(b) one or more solvents capable of dissolving the hydrophilic drug or its pharmaceutically acceptable salt to form a drug-solvent solution;

(c) a surfactant system comprising one or more surfactants, said surfactant system exhibiting a hydrophilic-lipophilic balance (HLB) value ranging from about 8 to about 17; and

(d) one or more hydrophilic carriers which are compatible with said drug-solvent solution and said surfactant system;

wherein the pharmaceutical composition is in a form of a self-emulsifying formulation for oral administration.

2. The oral self micro-emulsifying pharmaceutical composition of claim 1, which forms an emulsion with a particle size of less than about 800 nm when said pharmaceutical composition contacts an aqueous medium.

3. The oral self micro-emulsifying pharmaceutical composition of claim 1, wherein the hydrophilic drug is bendamustine or gemcitabine.

4. The oral self micro-emulsifying pharmaceutical composition of claim 1, wherein each of the one or more solvents is capable of dissolving about 1 part of a given hydrophilic drug or its pharmaceutically acceptable salt in less than 100 parts of the solvent.

5. The oral self micro-emulsifying pharmaceutical composition of claim 1, wherein the one or more solvents are selected from the group consisting of water, ethanol, polyethylene glycol (PEG), isopropanol (IPA), 1,2-propanediol (propylene glycol), glycerol, and acetic acid.

6. The oral self micro-emulsifying pharmaceutical composition of claim 5, which comprises water as the solvent.

7. The oral self micro-emulsifying pharmaceutical composition of claim 1, wherein the one or more surfactants are selected from the group consisting of polysorbate, poloxamers, oleoyl polyoxylglycerides, linoleoyl polyoxylglycerides, caprylocaproyl polyoxylglycerides, polyoxyethylene castor oil derivatives, polyoxyethylene alkyl ethers, sorbitan fatty acid esters, glyceryl monooleate, glyceryl monolinoleate, medium-chain triglycerides (MCT), polyglyceryl oleate, lauroyl polyoxylglyceride, stearoyl polyoxylglycerides, propylene glycol dicaprylocaprate, propylene glycol laurate, propylene glycol monolaurate, propylene glycol caprylate and propylene glycol monocaprylate, and combinations thereof.

8. The oral self micro-emulsifying pharmaceutical composition of claim 7, which comprise polysorbate and oleoyl polyoxylglycerides as the surfactants.

9. The oral self micro-emulsifying pharmaceutical composition of claim 1, wherein each of the one or more hydrophilic carriers is capable of dissolving about 1 part of a given hydrophilic drug or its pharmaceutically acceptable salt in about 10 to about 10,000 parts of the hydrophilic carrier.

10. The oral self micro-emulsifying pharmaceutical composition of claim 1, wherein the one or more hydrophilic carriers are selected from the group consisting of polysorbate, ethanol, polyethylene glycol (PEG), glycerol, 1,2-propanediol (propylene glycol), propylene carbonate (PC), diethylene glycol monoethyl ether, and combinations thereof.

11. The oral self micro-emulsifying pharmaceutical composition of claim 10, which comprises glycerol and PEG as the hydrophilic carriers.

12. The oral self micro-emulsifying pharmaceutical composition of claim 10, which comprises propylene glycol and PEG as the hydrophilic carriers.

13. The oral self micro-emulsifying pharmaceutical composition of claim 3, which has a pH above the 4.0.

14. The oral self micro-emulsifying pharmaceutical composition of claim 1, which comprises gemcitabine or its pharmaceutically acceptable salt, water, glycerol, PEG, polysorbate, and oleoyl polyoxylglycerides.

15. The oral self micro-emulsifying pharmaceutical composition of claim 1, which comprises gemcitabine or its pharmaceutically acceptable salt, water, propylene glycol, PEG, polysorbate, and oleoyl polyoxylglycerides.

16. The oral self micro-emulsifying pharmaceutical composition of claim 1, which comprises gemcitabine or its pharmaceutically acceptable salt, water, glycerol, PEG, polysorbate, oleoyl polyoxylglycerides, and TPGS.

17. A method for preparing an oral self micro-emulsifying pharmaceutical composition of claim 1, comprising mixing together the hydrophilic drug or its pharmaceutically acceptable salt thereof, the one or more solvents, the one or more hydrophilic carriers and the surfactant system to form the oral self micro-emulsifying pharmaceutical composition.

18. The method of claim 17, comprising mixing the hydrophilic drug or its pharmaceutically acceptable salt thereof with the one or more solvents and the one or more hydrophilic carriers first and further with the surfactant system.